Silicon Line®, une marque d'EverProX®, lance le nouveau chipset SerDes à très faible consommation MSDL™ (MIPI Serial Data Link), qui étend la connectivité MIPI D-PHY à 20 Gbit/s sur des distances de plusieurs dizaines de mètres
Source: PR Newswire

EverProX's Silicon Line launched the MSDL 20G SerDes chipset, supporting two simultaneous 10 Gbit/s MIPI D-PHY links over optical distances of several tens of meters or copper links up to 2 meters. The solution consumes 71 mW per optical link and 87 mW per electrical link, targeting multicamera AI, AR/VR, medical imaging, industrial robotics and defense applications. Chips and evaluation kits are available for early-access customer sampling, but no commercial revenue, volume-production timeline, or customer wins were disclosed.
Analysis
This is not yet a public-markets catalyst: early-access sampling implies no near-term revenue read-through, and the issuer is private. The investable implication is a design-architecture signal: as machine vision moves from single sensors to distributed multi-camera systems, cable mass, thermal budgets, EMI certification and installation complexity become system-level bottlenecks. Suppliers with optical interconnect exposure could gain share where long-reach, deterministic links displace shielded copper, but qualification cycles in medical, defense and industrial automation are typically 12-36 months.
The more relevant competitive pressure is on conventional automotive/industrial video-link and connector ecosystems rather than broad semiconductor vendors. Analog Devices (ADI), Texas Instruments (TXN), onsemi (ON), ams-OSRAM (AMS.DE) and Coherent (COHR) have adjacent exposure through industrial connectivity, machine vision, image sensors, VCSELs or optical components; however, none has disclosed a material dependency on this specific design win. The technical claims require independent validation of total system power, optical-module cost, error rates and interoperability—chip-level power savings can be overwhelmed by optics, connectors and host processing.
Consensus may overstate the immediate AR/VR opportunity: headset volumes remain constrained by consumer demand, whereas medical endoscopy, factory automation and defense platforms value EMI resilience and cable reduction enough to absorb optical-link costs. A broader adoption wave would be structurally positive for VCSEL and precision-optics demand, but it could be negative for commodity copper-cable content per installed vision node. Watch for named OEM design wins, production commitments, and evidence that the solution meets regulated reliability requirements rather than relying on evaluation-kit announcements.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.42
Key Decisions for Investors
- No directional position on this announcement alone; set a 6-12 month alert for disclosed production design wins or contract manufacturers attached to the platform, since sampling-stage launches rarely change estimates.
- Maintain a watchlist long bias toward COHR and AMS.DE only if industrial/medical optical-interconnect order commentary improves; use next earnings as confirmation and avoid attribution to this private vendor without customer evidence.
- For a 12-24 month thematic basket, prefer ADI over TXN for higher-value industrial automation and instrumentation exposure, but require evidence of rising machine-vision connectivity content; falsify on weakening industrial bookings or further inventory digestion.
- Monitor TE Connectivity (TEL) and Amphenol (APH) for a second-order risk: sustained optical substitution in high-EMI multi-camera systems could pressure copper harness content, though their broad connector portfolios make this immaterial absent volume adoption.
More News
- Saudis shut down oil pipeline as Houthis tighten grip on Red Sea shipping
- Saudi Arabia says East-West pipeline hit by drones launched from Iraq
- Nvidia in talks to invest up to $10 billion in Anthropic IPO
- The inside story on the historic U.S.-Venezuela oil deal and how it will work
- Apollo in talks to buy J&J orthopedics unit for nearly $20 billion
- Exclusive-Nvidia in talks to invest in Anthropic’s mega IPO, sources say